Redefining leishmaniasis therapy: Innovations in drug discovery and vaccine design
Microbial Pathogenesis · 2026-12 · 221 · 108845
DOI: 10.1016/j.micpath.2026.108845 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Microbial Pathogenesis, 2026-12. Verfasst von Swati Pal und 2 weiteren Autor:innen. Beteiligte Einrichtung: IKG Punjab Technical University, Kapurthala, Punjab, India; Pharmaceutical Research Division, Amar Shaheed Baba Ajit Singh Jujhar Singh Memorial Coll…. Hauptthemen laut MEDLINE: Leishmaniasis, Drug Discovery, Antiprotozoal Agents, Vaccine Development. Die Arbeit nennt 78 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- IKG Punjab Technical University, Kapurthala, Punjab, India; Pharmaceutical Research Division, Amar Shaheed Baba Ajit Singh Jujhar Singh Memorial College of Pharmacy, BELA, Ropar, Punjab, India; Faculty of Pharmaceutical…
- Pharmaceutical Research Division, Amar Shaheed Baba Ajit Singh Jujhar Singh Memorial College of Pharmacy, BELA, Ropar, Punjab, India.
- Faculty of Pharmaceutical Sciences, The ICFAI University, Himachal Pradesh, India. Electronic address: ravindersharma7@yahoo.com.
Zitieren
APA
Pal, S., Sharma, S., & Sharma, R. (2026). Redefining leishmaniasis therapy: Innovations in drug discovery and vaccine design. Microbial Pathogenesis, 221, 108845. https://doi.org/10.1016/j.micpath.2026.108845
Vancouver
Pal S, Sharma S, Sharma R. Redefining leishmaniasis therapy: Innovations in drug discovery and vaccine design. Microbial Pathogenesis. 2026;221:108845. doi:10.1016/j.micpath.2026.108845
BibTeX
@article{Pal2026,
author = {Pal, Swati and Sharma, Shailesh and Sharma, Ravinder},
title = {Redefining leishmaniasis therapy: Innovations in drug discovery and vaccine design},
journal = {Microbial Pathogenesis},
year = {2026},
volume = {221},
pages = {108845},
doi = {10.1016/j.micpath.2026.108845}
}
EUVIMED